Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ALS
ALS
After talks with FDA, a biotech prepares to submit its closely watched ALS drug
BioPharma Dive
Wed, 09/15/21 - 10:48 am
Amylyx Pharmaceuticals
FDA
ALS
AMX-0035
AZ’s Alexion takeover hits a snag, as Ultomiris flunks ALS trial
Pharmaforum
Sun, 08/22/21 - 09:50 pm
AstraZeneca
Ultomiris
ALS
Treg cell therapy showing promise in ALS trials: Coya Therapeutics
Biopharma Reporter
Mon, 08/2/21 - 09:34 pm
Coya Therapeutics
ALS
Treg cell therapy
clinical trials
Amylyx, faced with longer FDA path for promising ALS drug, gets major cash infusion
BioPharma Dive
Tue, 07/20/21 - 12:31 pm
Amylyx Pharmaceuticals
ALS
venture capital
FDA
AMX0035
AB Science Announces Significant Survival Data for Masitinib in ALS
BioSpace
Tue, 07/20/21 - 11:02 am
AB Science
ALS
clinical trials
masitinib
Eli Lilly makes modest bet on 'all-in-human' discovery outfit for ALS drugs, deepening bid in precision neurology
Endpoints
Thu, 07/8/21 - 11:02 am
Eli Lilly
Verge Genomics
drug development
drug discovery
artificial intelligence
ALS
Alzheimer's disease
Promised EAP Date Approaching for Biogen's Highly Publicized ALS Drug
BioSpace
Wed, 06/30/21 - 12:13 am
Biogen
tofersen
ALS
VectorY raises $38M to develop Alzheimer's, ALS gene therapies
Fierce Biotech
Tue, 06/15/21 - 11:37 pm
VectorY Therapeutics
gene therapy
ALS
Alzheimer's disease
CRISPR Therapeutics takes a swing at ALS gene editing in discovery deal with AAV upstart Capsida
Endpoints
Tue, 06/15/21 - 10:37 am
CRISPR Therapeutics
ALS
gene editing
Capsida
NurOwn: A Study in the Complexity of ALS Trials
BioSpace
Tue, 05/4/21 - 10:44 pm
BrainStorm Cell Therapeutics
NurOwn
ALS
clinical trials
Following pressure, Biogen to start compassionate use program for ALS drug tofersen
Seeking Alpha
Tue, 04/27/21 - 10:58 am
Biogen
ALS
tofersen
compassionate use guidelines
Amylyx Pharma’s ALS drug needs a Phase 3 study to support FDA submission
MedCity News
Thu, 04/15/21 - 11:56 pm
Amylyx
ALS
clinical trials
FDA
FDA faces backlash after seeking more data on an experimental ALS therapy
BioPharma Dive
Wed, 04/14/21 - 09:53 pm
ALS
AMX0035
Amylyx Pharmaceuticals
FDA
Ionis' Ups and Downs: Partnership with Progenity, 70% Job Cuts at Akcea and More
BioSpace
Wed, 04/7/21 - 07:15 pm
Ionis Pharmaceuticals
Progenity
ALS
clinical trials
FDA calls out Brainstorm’s ALS stem cell therapy, says data don’t show benefit
MedCity News
Thu, 03/4/21 - 09:53 am
BrainStorm Cell Therapeutics
ALS
stem cell therapy
clinical trials
FDA
Despite red flag from FDA, controversial ALS cell therapy developer says it may still march ahead anyway
Endpoints
Mon, 02/22/21 - 10:51 am
BrainStorm Cell Therapeutics
ALS
cell therapy
FDA
Stem cell therapy for ALS fails a large clinical trial
BioPharma Dive
Wed, 11/18/20 - 10:59 pm
ALS
clinical trials
stem cells
BrainStorm Therapeutics
Bristol Myers, insitro ally to apply machine learning to ALS R&D
Fierce Biotech
Wed, 10/28/20 - 10:35 am
Bristol-Myers Squibb
Insitro
machine learning
ALS
artificial intelligence
Early signs of survival benefit raise optimism around a small biotech's ALS drug
BioPharma Dive
Sun, 10/18/20 - 12:03 am
ALS
AMX0035
Amylyx Pharmaceuticals
Biogen teams up with gene-editing startup Scribe on ALS program
Pharmaforum
Thu, 10/8/20 - 11:09 am
Scribe Therapeutics
Biogen
ALS
CRISPR
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
next ›
last »